Circulating Tumor Cells in a Phase 3 Study of Docetaxel and Prednisone with or without Lenalidomide in Metastatic Castration-resistant Prostate Cancer

Published 2017 View Full Article

Authors

Keywords

Prostate cancer, Metastatic castration-resistant prostate cancer, Circulating tumor cells, Docetaxel, Lenalidomide

Journal

EUROPEAN UROLOGY

Volume 71, Issue 2, Pages 168-171

Publisher

Elsevier BV

Online

2016-08-12

DOI

10.1016/j.eururo.2016.07.051

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started